Capsule is a new kind of pharmacy that has invested in technology, experience, and care. Instead of mailing prescriptions in 10-14 days, Capsule hand deliver them on the same day patients see your doctor. They've engineered a holistic pharmacy experience that provides personalized and effortless care, setting a new standard for how people interact with their medications. This company was founded by Eric Kinariwala in 2016 and is headquartered in New York, NY.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/13/2023 | Series E | $100MM | $xx.xx | $45.81B | Cox Enterprises, Seedford Partners | |
Price per Share
$xx.xx
Shares Outstanding
34,112,229
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
16.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cox Enterprises, Seedford Partners
|
||||||
04/28/2021 | Series 1-D | $42.62MM | $xx.xx | $115.1B | Baillie Gifford, Durable Capital Partners, Ipd Capital, T. Rowe Price, Whale Rock Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
14,537,052
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
16.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Durable Capital Partners, Ipd Capital, T. Rowe Price, Whale Rock Capital Management
|
||||||
09/13/2019 | Series 1-C | $14.1MM | $xx.xx | $42.85B | 7 Global Capital, Evan Nehmadi, Glade Brook Capital Partners, G Squared, M13, Tcv, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
4,808,269
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
16.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7 Global Capital, Evan Nehmadi, Glade Brook Capital Partners, G Squared, M13, Tcv, Thrive Capital
|
||||||
08/13/2018 | Series 1-B | $17.8MM | $xx.xx | $12.65B | 7 Global Capital, Glade Brook Capital Partners, Reshape, Sandy Cass, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
6,193,457
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7 Global Capital, Glade Brook Capital Partners, Reshape, Sandy Cass, Thrive Capital
|
||||||
05/17/2017 | Series 1-A | $6.05MM | $xx.xx | $3.32B | Global Founders Capital, Palm Drive Capital, Sound Ventures, Thrive Capital, Virgin Group | |
Price per Share
$xx.xx
Shares Outstanding
3,415,659
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Global Founders Capital, Palm Drive Capital, Sound Ventures, Thrive Capital, Virgin Group
|